Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Internal Medicine • Myeloproliferative Neoplasms • Hematology • Essential Thrombocythemia
In which patients with essential thrombocythemia would you use ropeginterferon alfa-2b?
Answer from: at Academic Institution
Currently, the FDA's only indication for Besremi (ropeginterferon) is polycythemia vera (PV). I am not sure why this is since there is ample data on treating essential thrombocytosis (ET) patients with pegylated interferon. So, if still available, my answer covers the use of either. It also covers E...
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
In patients who progress on hydroxyurea and anagrelide or refractory to them.